Covea Finance Has $8.07 Million Stake in Zoetis Inc. $ZTS

Covea Finance reduced its position in Zoetis Inc. (NYSE:ZTS) by 75.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 64,164 shares of the company’s stock after selling 200,333 shares during the period. Covea Finance’s holdings in Zoetis were worth $8,073,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. CIBC Asset Management Inc grew its holdings in shares of Zoetis by 4.3% during the third quarter. CIBC Asset Management Inc now owns 251,495 shares of the company’s stock valued at $36,745,000 after buying an additional 10,434 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its holdings in shares of Zoetis by 6.5% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 295,482 shares of the company’s stock worth $43,235,000 after acquiring an additional 18,040 shares during the last quarter. Ninety One UK Ltd raised its holdings in shares of Zoetis by 19.6% in the 3rd quarter. Ninety One UK Ltd now owns 1,119,132 shares of the company’s stock worth $163,751,000 after acquiring an additional 183,686 shares during the last quarter. Quilter Plc lifted its position in Zoetis by 10.2% in the 3rd quarter. Quilter Plc now owns 438,959 shares of the company’s stock valued at $64,228,000 after acquiring an additional 40,615 shares in the last quarter. Finally, Swedbank AB boosted its stake in Zoetis by 60.4% during the 3rd quarter. Swedbank AB now owns 2,436,888 shares of the company’s stock valued at $356,565,000 after purchasing an additional 917,598 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on ZTS shares. Leerink Partners reissued a “market perform” rating on shares of Zoetis in a report on Tuesday, March 10th. Barclays started coverage on Zoetis in a report on Monday, December 8th. They issued an “equal weight” rating and a $136.00 target price on the stock. Piper Sandler reiterated a “neutral” rating and set a $135.00 price target (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. BTIG Research reissued a “buy” rating and issued a $160.00 price target on shares of Zoetis in a research report on Thursday, February 26th. Finally, Weiss Ratings upgraded Zoetis from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, March 12th. Six analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $152.91.

Zoetis Trading Down 0.5%

NYSE:ZTS opened at $115.43 on Friday. Zoetis Inc. has a 12 month low of $114.36 and a 12 month high of $172.23. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71. The firm’s 50 day moving average is $124.35 and its 200 day moving average is $130.60. The stock has a market capitalization of $48.73 billion, a PE ratio of 19.17, a price-to-earnings-growth ratio of 1.77 and a beta of 0.95.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. During the same period in the prior year, the company earned $1.40 earnings per share. Zoetis’s revenue was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Sell-side analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. Zoetis’s dividend payout ratio is presently 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.